Annual EBIT
-$127.06 M
-$41.27 M-48.10%
31 December 2023
Summary:
RAPT Therapeutics annual earnings before interest & taxes is currently -$127.06 million, with the most recent change of -$41.27 million (-48.10%) on 31 December 2023. During the last 3 years, it has fallen by -$73.85 million (-138.78%). RAPT annual EBIT is now -333.20% below its all-time high of -$27.95 million.RAPT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$19.79 M
+$9.54 M+32.53%
30 September 2024
Summary:
RAPT Therapeutics quarterly earnings before interest & taxes is currently -$19.79 million, with the most recent change of +$9.54 million (+32.53%) on 30 September 2024. Over the past year, it has increased by +$14.13 million (+41.66%). RAPT quarterly EBIT is now -136.61% below its all-time high of -$8.36 million, reached on 31 March 2018.RAPT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$114.85 M
+$14.13 M+10.96%
30 September 2024
Summary:
RAPT Therapeutics TTM earnings before interest & taxes is currently -$114.85 million, with the most recent change of +$14.13 million (+10.96%) on 30 September 2024. Over the past year, it has increased by +$3.42 million (+2.89%). RAPT TTM EBIT is now -1273.35% below its all-time high of -$8.36 million, reached on 31 March 2018.RAPT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAPT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -48.1% | +41.7% | +2.9% |
| 3 y3 years | -138.8% | -6.8% | -78.7% |
| 5 y5 years | -243.9% | -91.8% | -183.7% |
RAPT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -138.8% | at low | -9.7% | +41.7% | -78.7% | +11.0% |
| 5 y | 5 years | -243.9% | at low | -91.8% | +41.7% | -183.7% | +11.0% |
| alltime | all time | -333.2% | at low | -136.6% | +41.7% | -1273.3% | +11.0% |
RAPT Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$19.79 M(-32.5%) | -$114.85 M(-11.0%) |
| June 2024 | - | -$29.33 M(-9.8%) | -$128.98 M(+0.8%) |
| Mar 2024 | - | -$32.52 M(-2.1%) | -$128.02 M(+0.8%) |
| Dec 2023 | -$127.06 M(+48.1%) | -$33.22 M(-2.1%) | -$127.06 M(+7.4%) |
| Sept 2023 | - | -$33.92 M(+19.6%) | -$118.28 M(+11.5%) |
| June 2023 | - | -$28.36 M(-10.1%) | -$106.03 M(+9.8%) |
| Mar 2023 | - | -$31.56 M(+29.2%) | -$96.58 M(+12.6%) |
| Dec 2022 | -$85.80 M(+24.0%) | -$24.43 M(+12.7%) | -$85.80 M(+8.1%) |
| Sept 2022 | - | -$21.68 M(+14.6%) | -$79.40 M(+4.1%) |
| June 2022 | - | -$18.91 M(-9.0%) | -$76.25 M(+3.9%) |
| Mar 2022 | - | -$20.78 M(+15.2%) | -$73.42 M(+6.1%) |
| Dec 2021 | -$69.21 M | -$18.03 M(-2.7%) | -$69.21 M(+7.7%) |
| Sept 2021 | - | -$18.53 M(+15.2%) | -$64.26 M(+6.6%) |
| June 2021 | - | -$16.08 M(-2.9%) | -$60.31 M(+6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$16.56 M(+26.6%) | -$56.74 M(+6.6%) |
| Dec 2020 | -$53.21 M(+22.0%) | -$13.09 M(-10.3%) | -$53.21 M(+0.5%) |
| Sept 2020 | - | -$14.58 M(+16.5%) | -$52.94 M(+8.8%) |
| June 2020 | - | -$12.51 M(-4.0%) | -$48.68 M(+3.3%) |
| Mar 2020 | - | -$13.04 M(+1.7%) | -$47.13 M(+8.0%) |
| Dec 2019 | -$43.63 M(+18.1%) | -$12.81 M(+24.2%) | -$43.63 M(+7.8%) |
| Sept 2019 | - | -$10.31 M(-5.9%) | -$40.49 M(-0.6%) |
| June 2019 | - | -$10.96 M(+14.8%) | -$40.72 M(+6.8%) |
| Mar 2019 | - | -$9.54 M(-1.3%) | -$38.13 M(+3.2%) |
| Dec 2018 | -$36.95 M(+26.0%) | -$9.67 M(-8.3%) | -$36.95 M(+35.5%) |
| Sept 2018 | - | -$10.54 M(+26.0%) | -$27.28 M(+63.0%) |
| June 2018 | - | -$8.37 M(+0.1%) | -$16.73 M(+100.1%) |
| Mar 2018 | - | -$8.36 M | -$8.36 M |
| Dec 2017 | -$29.33 M | - | - |
FAQ
- What is RAPT Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for RAPT Therapeutics?
- What is RAPT Therapeutics annual EBIT year-on-year change?
- What is RAPT Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for RAPT Therapeutics?
- What is RAPT Therapeutics quarterly EBIT year-on-year change?
- What is RAPT Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for RAPT Therapeutics?
- What is RAPT Therapeutics TTM EBIT year-on-year change?
What is RAPT Therapeutics annual earnings before interest & taxes?
The current annual EBIT of RAPT is -$127.06 M
What is the all time high annual EBIT for RAPT Therapeutics?
RAPT Therapeutics all-time high annual earnings before interest & taxes is -$27.95 M
What is RAPT Therapeutics annual EBIT year-on-year change?
Over the past year, RAPT annual earnings before interest & taxes has changed by -$41.27 M (-48.10%)
What is RAPT Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of RAPT is -$19.79 M
What is the all time high quarterly EBIT for RAPT Therapeutics?
RAPT Therapeutics all-time high quarterly earnings before interest & taxes is -$8.36 M
What is RAPT Therapeutics quarterly EBIT year-on-year change?
Over the past year, RAPT quarterly earnings before interest & taxes has changed by +$14.13 M (+41.66%)
What is RAPT Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of RAPT is -$114.85 M
What is the all time high TTM EBIT for RAPT Therapeutics?
RAPT Therapeutics all-time high TTM earnings before interest & taxes is -$8.36 M
What is RAPT Therapeutics TTM EBIT year-on-year change?
Over the past year, RAPT TTM earnings before interest & taxes has changed by +$3.42 M (+2.89%)